Endostatin is a potential inhibitor of Wnt signaling. - Wikidata - wikimedia - TriplyDB

Endostatin is a potential inhibitor of Wnt signaling.

Endostatin is a potential inhibitor of Wnt signaling.

http://www.wikidata.org/entity/Q36325183

about

Type XVIII collagen degradation products in acute lung injury Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins SP100 inhibits ETS1 activity in primary endothelial cells The Wnt-dependent signaling pathways as target in oncology drug discovery The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment Multiplexin promotes heart but not aorta morphogenesis by polarized enhancement of slit/robo activity at the heart lumen Lack of collagen XVIII/endostatin exacerbates immune-mediated glomerulonephritis.Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells.Non-canonical Wnt signaling and N-cadherin related beta-catenin signaling play a role in mechanically induced osteogenic cell fate.Secreted frizzled-related protein 4: an angiogenesis inhibitor.Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family.Regulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous Angioinhibitors.Wnt/Frizzled signaling in the vasculature: new angiogenic factors in sight.Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing Angiogenesis in diabetes and obesity Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)Roles of main pro- and anti-angiogenic factors in tumor angiogenesis Extension of the in vivo half-life of endostatin and its improved anti-tumor activities upon fusion to a humanized antibody against tumor-associated glycoprotein 72 in a mouse model of human colorectal carcinoma.Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and beta-catenin levels.Endostatin enhances radioresponse in breast cancer cells via alteration of substance P levels.The clinical potential of antiangiogenic fragments of extracellular matrix proteins Targeting integrins for the control of tumour angiogenesis.Structural basis for the functions of endogenous angiogenesis inhibitors.Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers Endostatin, an inhibitor of angiogenesis, decreases after bidirectional superior cavopulmonary anastamosis.Improved biological activity of a mutant endostatin containing a single amino-acid substitution A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanoma.Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: "seed and soil" theory revisited.Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect.Limbal stem cell deficiency and corneal neovascularization.Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis.Wnt pathway antagonists and angiogenesis.Antiangiogenic and anticancer molecules in cartilage.Endostatin overexpression specifically in the lens and skin leads to cataract and ultrastructural alterations in basement membranes.ATP citrate lyase knockdown impacts cancer stem cells in vitro.Negative regulators of angiogenesis: important targets for treatment of exudative AMD.AAV-P125A-endostatin and paclitaxel treatment increases endoreduplication in endothelial cells and inhibits metastasis of breast cancer.A role for planar cell polarity signaling in angiogenesis.

P2860

Q22000109-3BAFB52E-C0A3-4176-A0E8-FDE7903A7144 Q24299560-31FFD240-3D9C-4700-9414-6C29B140B1B5 Q24321596-26606591-4958-4613-9CD0-F79F3C569085 Q24652979-B5939782-B1EA-4DED-B621-76E2A84D622E Q24681859-A25E2B8C-3DFF-4240-A562-4559E85F4092 Q24803543-41553D15-2F8C-4A4F-96FE-C7CC3FC66B5F Q27321646-8EF6CE22-51D7-494B-9B8D-D8DA18AD4A85 Q30497785-879A38B5-7FB2-41AB-A490-48F3216369D9 Q33211600-8E932FA6-D71C-4085-B663-2AD28DDAE980 Q33436209-76613611-504E-43E4-B287-2FF8D28AC79D Q33703825-21D9F0AA-7B93-48D1-AAE9-6D42B550986E Q33859420-CE326CC2-85FB-4C3B-81B2-AE137AC4AC68 Q34230899-A0E3059A-190F-4447-AFC3-5CCF88713153 Q34528832-C376DC2E-94B4-4A89-93B4-F0A73359DB47 Q35084866-2931E15C-CF03-4B88-903B-C60F2A1340E3 Q35153884-110FFBF0-7F47-455B-A7E5-95D7D5524B53 Q35662667-EEA0FCC8-6367-4E63-8700-F4C9AEAE3CBD Q35668936-F6493E9B-8F66-4D87-A9ED-903E9A7FA5FC Q35740177-47714774-0AFF-4202-B247-793BBC2EB9EE Q35749152-49EE692A-8A27-4D44-8547-CB6A86CA6507 Q35893364-1ED030AE-10FD-406A-BD37-4E7915A23991 Q36126632-EF546267-5103-4E0F-8FEB-C9E67C5DA7A5 Q36290509-DC2FEAC6-0D4C-457E-96C4-C3FAD4BA67A8 Q36322066-68CCD977-85EA-4436-8F28-DED97F08DA14 Q36547755-4C5B1765-BAF6-4B1A-887C-22F76D2A0935 Q36578668-1090575A-30FC-42E0-95B8-192AFFDC474A Q36615857-11F9A4F8-7451-40B6-97A9-ECE51642C818 Q36694928-70E3E2D2-7810-4311-8520-8B9129D736B9 Q36984477-9A8289BA-2674-4638-8E47-56923546247B Q37077230-EB833D2D-73C1-4235-846E-F068E7E383AB Q37326940-B0B8CE08-2996-45BF-91DD-074ED69508E8 Q37479357-8D923641-A8D9-4575-8712-9EEA8CED361E Q37710265-53716829-09F5-4052-8F2C-56CCBE2FAAE4 Q37825843-27DB9A8D-5A74-40C2-ADB1-69E4BF49F31E Q38007565-C67373D5-2F29-4925-A68F-184CF31A392F Q38584966-2205727F-7480-4CC6-ACD4-C7D5C55098E8 Q39134010-B6B9E887-0CE9-49D1-9B50-8E95039E9D30 Q39416208-371FA61F-0856-441E-A8AA-58D5BA583EF6 Q39655433-02258310-6AF7-4CDF-8DD1-4D143C559206 Q39938975-4844805E-C284-45F4-9ED4-80589F26C25F

P2860

Endostatin is a potential inhibitor of Wnt signaling.

http://www.wikidata.org/entity/Q36325183

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Endostatin is a potential inhibitor of Wnt signaling.

@ast

Endostatin is a potential inhibitor of Wnt signaling.

@en

type

label

Endostatin is a potential inhibitor of Wnt signaling.

@ast

Endostatin is a potential inhibitor of Wnt signaling.

@en

prefLabel

Endostatin is a potential inhibitor of Wnt signaling.

@ast

Endostatin is a potential inhibitor of Wnt signaling.

@en

P1433

Q36325183-BF55C403-B2B3-4B34-B081-70A28A30E4DB

P1476

Q36325183-77AE80E1-C4AB-42A8-BB5A-B0CABCE98391

P2093

Q36325183-5B313A21-9079-4226-9B25-0333F7846DBE

Q36325183-63AAC64B-02A5-4064-8CE0-38AC37213DCB

Q36325183-729371B0-562D-44D7-A824-579284CC5021

Q36325183-81FB634C-8E38-433E-A642-5A95CBF0E5E4

Q36325183-97D9638A-759F-4406-94A5-655348E79AB4

Q36325183-A0F5198B-7020-423E-8EE4-FF08F3FA1B2F

Q36325183-A8EF573C-0305-46F4-A1FD-DBEBCE63F070

Q36325183-B000DD12-0D1D-48A4-B4B8-75B344F5E364

Q36325183-D82947C3-B7B7-4B60-9293-F3F583FA32A6

Q36325183-E361DCF6-9045-47A7-890C-FCE8C48AF230

P2860

Q36325183-0058CCF9-4ED5-4034-8118-D7371AFE9F53

Q36325183-00B4FBDC-9C66-4564-9E93-03B8DE677B7A

Q36325183-04628FB7-A8A4-4723-921F-923286C6B349

Q36325183-07864458-09AA-4FFF-8FDB-154C06743909

Q36325183-116193D3-69DA-4228-9209-E1B23535BC8B

Q36325183-12697DB2-65B2-4E36-BA8B-51237D972E32

Q36325183-17EAD5B2-B427-40B8-9333-CE617CFA6C35

Q36325183-20A1104A-31DF-4C06-B529-BBEAA26817A4

Q36325183-25C72487-0BCC-4BC8-AD0D-6A2B32193CC2

Q36325183-264BCC6C-2862-4DA8-B149-AB0B7AF46F56

P304

Q36325183-CA8E154B-66E9-412A-8255-673807E56FFD

P31

Q36325183-EE44276F-14C8-43D8-BF0F-820237850D2F

P356

Q36325183-A0BCC0C3-5E90-4B1E-A860-5F03F2C470C6

P407

Q36325183-E832FC46-FCBB-4497-B880-4FF073B3E228

P433

Q36325183-E8A3C973-531F-4167-A7DD-C1FB446C3B10

P478

Q36325183-06C3CBD8-050C-4328-9A0B-D40046902E66

P50

Q36325183-9E9C837F-D6B3-4D3E-B9BE-962BF92A0562

P577

Q36325183-FEB34595-31BE-4520-9930-97FD144194F8

P5875

Q36325183-D3D224DF-1BD3-482A-BD37-57C0C7F5C568

P698

Q36325183-A837C089-F59E-4B9B-9766-C23C38DB4B13

P932

Q36325183-62CF0E07-B2B2-46CF-8348-21DDDB3AF36B

P356

P1433

Journal of Cell Biology

P1476

Endostatin is a potential inhibitor of Wnt signaling.

@en

P2093

Barden Chan

http://www.w3.org/2001/XMLSchema#string

Guang Hu

http://www.w3.org/2001/XMLSchema#string

Jian Tang

http://www.w3.org/2001/XMLSchema#string

Joachim Gloy

http://www.w3.org/2001/XMLSchema#string

Jun-ichi Hanai

http://www.w3.org/2001/XMLSchema#string

Ramani Ramchandran

http://www.w3.org/2001/XMLSchema#string

Sergei Sokol

http://www.w3.org/2001/XMLSchema#string

Sujata Kale

http://www.w3.org/2001/XMLSchema#string

Vikas P Sukhatme

http://www.w3.org/2001/XMLSchema#string

Vivek Jha

http://www.w3.org/2001/XMLSchema#string

P2860

DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability

Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome)

Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein

GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis

Identification of c-MYC as a target of the APC pathway

A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

Siah-1 N-terminal RING domain is required for proteolysis function, and C-terminal sequences regulate oligomerization and binding to target proteins

Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box

P304

529-539

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1083/JCB.200203064

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

158

http://www.w3.org/2001/XMLSchema#string

P50

S Ananth Karumanchi

P577

2002-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11234412

http://www.w3.org/2001/XMLSchema#string

P698

12147676

http://www.w3.org/2001/XMLSchema#string

P932

2173844

http://www.w3.org/2001/XMLSchema#string